n-3 polyunsaturated fatty acid supplementation (Pikasol) in men with moderate and severe hypertriglyceridaemia: a dose-response study

Ann Nutr Metab. 1992;36(5-6):283-7. doi: 10.1159/000177731.

Abstract

The effect of n-3 fatty acids in 11 men with hypertriglyceridaemia was investigated. The subjects were given daily supplements with three different doses of n-3 fatty acids for 8-week periods. The supplements given were 2, 4 and 9 g of n-3 fatty acids/day, respectively. Total cholesterol, triglycerides and the ratio of total cholesterol to HDL-cholesterol significantly decreased with all three doses in a dose-dependent way. HDL-cholesterol increased in a dose-dependent fashion, while apolipoproteins A1 and B were unaltered by the supplements apart from a small increase in apolipoprotein A1 after the lowest dose of n-3 fatty acids. The greatest effect was observed after 2 g of n-3 fatty acids/day.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apolipoprotein A-I / metabolism
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Dietary Fats, Unsaturated / administration & dosage
  • Dietary Fats, Unsaturated / therapeutic use*
  • Fatty Acids, Omega-3 / administration & dosage
  • Fatty Acids, Omega-3 / therapeutic use*
  • Fish Oils / administration & dosage
  • Fish Oils / therapeutic use
  • Humans
  • Hypertriglyceridemia / blood
  • Hypertriglyceridemia / diet therapy*
  • Male
  • Middle Aged
  • Triglycerides / blood

Substances

  • Apolipoprotein A-I
  • Cholesterol, HDL
  • Dietary Fats, Unsaturated
  • Fatty Acids, Omega-3
  • Fish Oils
  • Triglycerides
  • Cholesterol